Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB291204

E2F8 Antibody, PE, Novus Biologicals™
SDP

Catalog No. NB291204 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB291204 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB291204 Supplier Novus Biologicals Supplier No. NBP152650PE
Add to Cart
Add to Cart

Description

Rabbit Polyclonal Antibody

E2F8 Polyclonal antibody specifically detects E2F8 in Human samples. It is validated for Western Blot, Immunoprecipitation

Specifications

Antigen E2F8
Applications Western Blot, Immunoprecipitation
Classification Polyclonal
Conjugate PE
Dilution Western Blot, Immunoprecipitation
Formulation PBS
Gene Alias E2F family member 8, E2F transcription factor 8, E2F-8, FLJ23311, transcription factor E2F8
Host Species Rabbit
Immunogen The immunogen for this product maps to a region between residue 817 and 867 of human E2F Transcription Factor 8 using the numbering given in entry NP_078956.2 (GeneID 79733).
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cell Cycle and Replication
Primary or Secondary Primary
Gene ID (Entrez) 79733
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.